Outcome of Board Meeting held on March 24, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Aptus Pharma, at its meeting on March 24, 2026, approved an increase in the company's Authorised Share Capital from INR 7.15 Crore (71,50,000 equity shares of Rs. 10) to INR 25 Crore (2,50,00,000 equity shares of Rs. 10), subject to shareholder approval. The Board also recommended a Bonus Issue in the ratio of 3:2, meaning 3 bonus equity shares for every 2 shares held by shareholders, also subject to member approval. A Postal Ballot Notice was approved to seek shareholder consent for both items, with CDSL appointed as the e-voting agency and a Scrutinizer appointed to oversee the process. The Board meeting ran from 5:00 PM to 7:15 PM.
The 3:2 bonus issue is rewarding for existing shareholders as it increases their holdings without additional cost, though it will dilute the share price proportionally. The hike in authorised capital is a necessary step to accommodate the bonus issue. Both proposals now require shareholder approval via postal ballot, after which the bonus shares will be allotted to eligible members.